Transcutaneous Intraluminal Impedance Measurement for Minimally Invasive Monitoring of Gastric Motility: Validation in Acute Canine Models

Figure 4

Combined plot of the raw signals and the 1-minute motility indices for an active pill in the baseline state (seconds 0–1800) and after the administration of neostigmine (seconds 1800–3600). The 1-minute duration for the administration of neostigmine is denoted by a thick vertical line.